KAS
CELU icon

Kestra Advisory Services’s Celularity CELU Stock Holding History

Kestra Advisory Services’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,691
Closed -$4.18K – 2464
2023
Q4 		$4.18K Hold
1,691
– – ﹤0.01% 2266
2023
Q3 		$3.75K Hold
1,691
– – ﹤0.01% 2102
2023
Q2 		$9.01K Sell
1,691
-100
-6% -$641 ﹤0.01% 2093
2023
Q1 		$11.1K Buy
+1,791
New +$14.4K ﹤0.01% 2031

Other funds holding CELU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $696M AUM 46.48% 1-Year Est. Return

Kestra Advisory Services's CELU Position: Q1 2024 in Review

Kestra Advisory Services sold out of Celularity (CELU) in Q1 2024, closing a stake of 1,691 shares — an estimated $4.18K sold.

Kestra Advisory Services first reported a position in CELU in Q1 2023 and held it in 4 quarters. The position peaked at $11.1K in Q1 2023. 30 funds tracked by Wall St. Rank hold CELU as of Q1 2024.

  • Kestra Advisory Services reported no remaining Celularity position as of Q1 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 1,691 Celularity shares in Q1 2024, an estimated $4.18K.
  • Kestra Advisory Services first reported a position in Celularity in Q1 2023 and held it in 4 quarters.
  • Kestra Advisory Services's Celularity position peaked at $11.1K in Q1 2023.
  • 30 funds tracked by Wall St. Rank held Celularity as of Q1 2024.

Based on Kestra Advisory Services's 13F filing for Q1 2024, filed 15 May 2024.